SCHEMBL29965248

SCHEMBL29965248

CC1=C(CCCCCCCCCCCCCCCO)C(C)(C)CCC1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.45
MAPT P10636 3/20 0.45
GAA P10253 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
LMNA P02545 1/20 0.44
RARB P10826 2/20 0.41
RARG P13631 2/20 0.41
RARA P10276 1/20 0.41
RXRA P19793 1/20 0.41
TRPA1 O75762 3/20 0.38
ALOX15 P16050 2/20 0.38
ALOX5 P09917 1/20 0.38
ACHE P22303 1/20 0.37
ACE2 Q9BYF1 4/20 0.36
PDCD1 Q15116 3/20 0.36
CD274 Q9NZQ7 3/20 0.36
CYP1A2 P05177 1/20 0.35
NR1I2 O75469 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7017316 1.00 ALDH1A1 (0.45) ALDH1A1MAPTGAANPSR1MEN1
SCHEMBL7185668 1.00 ALDH1A1 (0.45) ALDH1A1MAPTGAANPSR1MEN1
SCHEMBL9266425 1.00 ALDH1A1 (0.45) ALDH1A1MAPTGAANPSR1MEN1
SCHEMBL4304302 0.85 ALDH1A1 (0.49) ALDH1A1MAPTGAANPSR1MEN1
SCHEMBL11492167 0.82 ALDH1A1 (0.43) ALDH1A1MAPTGAANPSR1MEN1
SCHEMBL15082362 0.81 RARB (0.49) ALDH1A1MAPTGAANPSR1MEN1
SCHEMBL14157557 0.81 RARB (0.49) ALDH1A1MAPTGAANPSR1MEN1
SCHEMBL3186206 0.80 ALDH1A1 (0.44) ALDH1A1MAPTGAANPSR1MEN1
SCHEMBL25229798 0.80 ALDH1A1 (0.40) ALDH1A1MAPTGAANPSR1MEN1
SCHEMBL17448809 0.79 RARB (0.41) ALDH1A1MAPTGAANPSR1MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11485696-B2 Manufacturing method for high-purity cyclohexenone long-chain alcohol TAIHO PHARMACEUTICAL CO., LTD. (JP) 2022-11-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11485696-B2 Manufacturing method for high-purity cyclohexenone long-chain alcohol ADH1A, ADH1C, HSD17B12 ALDH1A1 37/4885MAPT 1925/4885GAA 3216/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.